Page last updated: 2024-08-16

potassium chloride and verlukast

potassium chloride has been researched along with verlukast in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abram, TS; Cuthbert, NJ; Gardiner, PJ; Norman, P; Tudhope, SR1
Gopalakrishnan, V; Kaul, C; McNeill, JR; Poduri, R; Shastri, S; Wilson, TW1
Bessard, G; Caron, F; Devillier, P; Faure, P; Hakim, A; Halimi, S; Hardy, G; Morel, S; Peoc'h, M; Stanke-Labesque, F1

Other Studies

3 other study(ies) available for potassium chloride and verlukast

ArticleYear
Characterisation of leukotriene receptors on rat lung strip.
    European journal of pharmacology, 1994, Dec-12, Volume: 271, Issue:1

    Topics: Animals; Dicarboxylic Acids; In Vitro Techniques; Indazoles; Leukotriene Antagonists; Leukotrienes; Lung; Male; Muscle Contraction; Muscle, Smooth; Potassium Chloride; Propionates; Quinolines; Rats; Rats, Wistar; Receptors, Leukotriene; SRS-A

1994
Cysteinyl leukotrienes mediate enhanced vasoconstriction to angiotensin II but not endothelin-1 in SHR.
    American journal of physiology. Heart and circulatory physiology, 2001, Volume: 281, Issue:1

    Topics: Angiotensin II; Animals; Benzoquinones; Endothelin-1; Hypertension; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Male; Potassium Chloride; Propionates; Quinolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Splanchnic Circulation; Vasoconstriction

2001
Cysteinyl leukotrienes modulate angiotensin II constrictor effects on aortas from streptozotocin-induced diabetic rats.
    Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:11

    Topics: Angiotensin II; Animals; Aorta; Benzoquinones; Diabetes Mellitus, Experimental; Insulin; Leukotriene Antagonists; Leukotriene E4; Lipoxygenase Inhibitors; Male; Organ Culture Techniques; Potassium Chloride; Propionates; Quinolines; Rats; Rats, Wistar; SRS-A; Vasoconstriction; Vasoconstrictor Agents

2001